“…Submissions were received from all around the world and the breadth of the topics covered is remarkable. Several of the topic areas that the articles discuss are antiviral drugs ( Wang and Chen, 2020 ), drug discovery ( Madadlou, 2020 ; Soni et al, 2020 ), drug-related adverse events ( Paniri et al, 2020 ), drug repurposing or adjunct therapies ( Bibi et al, 2020 ; Costa et al, 2020 ; El Tabaa and El Tabaa, 2020 ; Habibzadeh et al, 2020 ; Islam et al, 2020 ; Lopachev et al, 2020 ; Monji et al, 2020 ; Omolo et al, 2020 ; Otreba et al, 2020 ), immunopharmacology ( Booz et al, 2020 ), inflammatory pathways ( Yarmohammadi et al, 2020 ), involvement of the renin-angiotensin system ( Kaur et al, 2020 ; Sharifkashani et al, 2020 ; Vitiello and Ferrara, 2020 ), molecular docking and modeling studies ( Deshpande et al, 2020 ; Vijayakumar et al, 2020 ), natural product-derived drugs or supplements ( Sahebnasagh et al, 2020 ; Tang et al, 2020 ), potential therapeutic targets ( Krishna et al, 2020 ; Sureda et al, 2020 ), real-world developments and pharmacotherapeutics ( Awasthi et al, 2020 ; Chibber et al, 2020 ; Khan et al, 2020 ; Lam et al, 2020 ; Marcolino et al, 2020 ; Monpara et al, 2020 ; Nittari et al, 2020 ; Samudrala et al, 2020 ), and targeting oxidative stress ( Alamdari et al, 2020 ). These are not exclusive and some overlap of course occurs among the articles in the areas that are discussed, but each contribution offers a unique perspective on the current approaches of the discipline called pharmacology.…”